ArticleJournal of translational medicine2026
Exosomal lncRNA SILC1 from bicalutamide-activated mesenchymal stem cells promotes prostate cancer survival and bicalutamide resistance via the miR-577/RHOA axis.
Jiayin Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.